Highlights d BMI1 is required at the pro-B cell to pre-B cell transition in a cell-autonomous manner 
The process of V(D)J recombination presents inherent risks to the organism because of the generation of double-strand breaks and subsequent non-homologous end joining of DNA fragments at the Ig loci. Thus, numerous mechanisms exist to ensure the proper generation of a clonal surface BCR on B cells while preventing deleterious events. These include the sequential rearrangement of Ig loci, with several checkpoints along the sequential development to assess rearrangement status, and the programming of developing B cells for either clonal expansion or apoptosis, depending on pre-BCR and BCR signaling cues (Melchers, 2015) . While extensive work has elucidated many of these mechanisms, our understanding of the molecular pathways critical for B cell development remains fragmentary.
Polycomb group (PcG) proteins are a group of regulatory factors that form multimeric protein complexes and are critical for maintaining cell identity and cell proliferation by modifying chromatin structure and silencing genes (Sauvageau and Sauvageau, 2010) . Polycomb repressive complex 1 (PRC1) and polycomb repressive complex 2 (PRC2) were the earliest complexes described, although more recent work has identified both alternative and novel polycomb complexes. The core components of PRC1 consist of one member of each CBX, HPH, PCGF, and RING1 protein family, which monoubiquitinate histone H2A on lysine 119 (H2AK119), whereas the core components of PRC2 are EED, Suz12, EZH1/2, and RBBP4/7, which methylate H3K27 (Di Croce and Helin, 2013; Simon and Kingston, 2013 ). PRC1 and PRC2 are thought to cooperate to regulate gene expression, because PRC2 deposition of H3K27me3 recruits PRC1 through its CBX family member (Blackledge et al., 2015) . However, inactivation of core PRC2 factors in mammalian cells only partially affects PRC1 recruitment to its target loci and minimally changes global H2AK119ub levels, suggesting that PRC2-independent mechanisms exist for PRC1 recruitment (Tavares et al., 2012) .
Through genetic studies in the mouse, it became apparent that PcG proteins are critical for B cell lymphopoiesis. EZH2 regulates distal V H gene usage during V H -DJ H recombination and prevents IgL loci rearrangement in pro-B cells (Mandal et al., 2011; Su et al., 2003) . The PRC1 component BMI1, also known as PCGF4, is required for normal lymphocyte development at least partly through the repression of the Ink4/Arf locus, which encodes the two tumor suppressor proteins, p16
INK4A and p19 ARF (Bruggeman et al., 2005; Oguro et al., 2010) . In developing T cells, BMI1 prevents premature p19 ARF -mediated stabilization of p53 to promote the proliferation and survival of progenitor T cells in response to pre-T cell receptor (TCR) signaling (Miyazaki et al., 2008) . However, Bmi1 À/À Ink4a/Arf À/À mice still exhibit defective B cell lymphopoiesis, suggesting that BMI1 functions partly through Ink4a/Arf-independent mechanisms during B cell development (Oguro et al., 2010) . We found that BMI1 is required for pro-B cells to differentiate into pre-B cells in a cell-autonomous manner. Loss of BMI1 results in the upregulation of p53 target genes in pro-B cells, precluding the expansion of these cells at the large pre-B stage. Furthermore, expression of rearranged Igh genes and production of the Igm chain are impaired in Bmi1 À/À pro-B cells. Accordingly, introduction of a pre-rearranged Igh allele partially restored B cell development in Bmi1 À/À mice. Altogether, these results identify a critical role for BMI1 in B cell development through the regulation of rearranged Igh gene expression and expansion of pre-B cells.
RESULTS

BMI1 Is Required for the Pro-B Cell to Pre-B Cell Transition
Previous studies have identified BMI1 as essential for B cell development in the mouse (Oguro et al., 2010; van der Lugt et al., 1994) . However, the mechanisms that BMI1 engages to promote B cell development remain unknown. To begin to dissect the function of BMI1 in progenitor B cells, we first assessed its expression levels throughout early B cell development using data acquired through the Immunological Genome Project (Heng et al., 2008; Painter et al., 2011) . Bmi1 is highly expressed in pro-B cells and large pre-B cells and is downregulated as large pre-B cells transition into small pre-B cells ( Figure S1A ). The expression of Cdkn2a, which encodes the tumor suppressor proteins p16 INK4A and p19 ARF and is repressed by BMI1, inversely correlates with Bmi1 expression at the pro-B cell to pre-B cell transition ( Figure S1A ). This correlation disappears in mature B cells, likely pointing to a more critical role for a Bmi1-Cdkn2a axis at the pro-B cell to pre-B cell transition. The high expression of Bmi1 and the resulting repression of Cdkn2a early in B cell development are reminiscent of what has been observed in early T cell development, in which BMI1 represses p19 ARF to prevent apoptosis in proliferating DN3 T cells (Miyazaki et al., 2008) . Furthermore, the inverse correlation of Bmi1 and Cdkn2a levels is consistent with studies demonstrating a modest rescue of B cell development in Bmi1 À/À Ink4a/Arf À/À mice (Miyazaki et al., 2008; Oguro et al., 2010 Figure S1B ). The differentiation block at the pro-B cell to pre-B cell transition resulted in drastically fewer mature B cells in the peripheral blood and spleen of Bmi1 À/À mice and a corresponding increase in the frequency of CD11b + myeloid cells (Figures 1C and 1D) . Consistent with previous reports (van der Lugt et al., 1994) , we observed a drastic reduction in the cellularity of various hematopoietic organs of Bmi1 À/À mice as a consequence of the overall reduction in lymphocyte numbers ( Figure S1C ).
Reduced Igm Chain Expression in
The pro-B cell to pre-B cell transition and subsequent expansion of large pre-B cells depend on the successful rearrangement of the Igh locus, the expression of Igm chain, the assembly of a pre-BCR on the surface of the cell, and signaling downstream of the pre-BCR. Failure in any of these steps will impair pro-B cell to pre-B cell differentiation (Herzog et al., 2009) . We therefore determined whether BMI1 was required for the expression of Igm chain in pro-B cells. By intracellular flow cytometry analysis, we observed a decrease in the frequency of pro-B cells expressing Igm chain in Bmi1 À/À mice to about half of the levels observed in Bmi1 +/+ mice ( Figure 2A ). In addition, we observed a decrease in the median Igm fluorescence intensity in Igm-expressing pro-B cells from Bmi1 À/À mice ( Figure 2B ). Figure S2A ). Because the PRC2 component EZH2 is required for distal V H gene usage (Su et al., 2003) , we tested whether BMI1 similarly enabled distal V H gene usage. On genomic DNA isolated from pro-B cells, we performed semiquantitative PCR using degenerative forward primers that amplify either V H 7183 genes or V H J558 genes and a reverse primer specific to the J H 3 gene. Bmi1 À/À pro-B cells and their wild-type counterparts contained comparable levels of DNA that had recombined either V H 7183 or V H J558 genes with DJ H genes ( Figure 2C ). In addition, we isolated and sequenced individual VDJ H joints from Bmi1 +/+ and Bmi1 À/À pro-B cells using a promiscuous forward primer that amplifies various genes across all V H families. Again, we observed no difference in the ratio of proximal to distal V H gene usage between Bmi1 +/+ and Bmi1 À/À pro-B cells, supporting the conclusion that BMI1 is not required for VDJ H recombination in pro-B cells ( Figure 2D ). In contrast, when we assessed the expression levels of rearranged Igh genes, we observed a drastic reduction in the expression levels of all V H family genes tested in Bmi1 À/À pro-B cells, consistent with a combined decreased frequency of Bmi1
BMI1 Is
pro-B cells expressing Igm and decreased Igm protein levels in Igm-expressing Bmi1 À/À pro-B cells ( Figure 2E ). The decrease in rearranged Igh gene expression was not the result of a generic reduction in expression at the Igh locus, because we detected no difference in the expression of D H -Cu transcripts ( Figure 2E ). Altogether, these data support a model in which BMI1 is dispensable for VDJ H recombination but is critical for expression of recently rearranged VDJ H genes in pro-B cells.
BMI1 Is Not Required for Igh Germline Transcription or
Igh Contraction PRC1 has been shown to regulate high-order chromatin architecture (Simon and Kingston, 2013) . For RAG complexes to access V H genes and initiate recombination, the surrounding chromatin needs to be accessible (Ebert et al., 2013; Fuxa et al., 2004) . The transcription of Igh genes in germline configuration (germline transcription) has been hypothesized to be critical for RAG accessibility to these genes (Yancopoulos and Alt, 1985) . We therefore first assessed whether BMI1 loss altered the ability of the germline Igh loci to be transcribed in pro-B cells as a surrogate assay for chromatin accessibility. However, we did not observe differences in germline transcription for either V H 7183 or V H J558 gene families between Bmi1 +/+ and Bmi1 À/À pro-B cells ( Figure S2B Figure 3D ). Altogether, these data demonstrate that bypassing VDJ H recombination enables Bmi1 À/À pro-B cells to express Igm and subsequently differentiate.
BMI1 Loss Results in the Upregulation of p53 Signaling in Pro-B Cells
Although expression of a pre-rearranged Igh locus partially rescues B cell development in Bmi1 À/À mice, Bmi1 À/À B1.8i + bone marrow still contains lower frequencies and numbers of pre-B cells compared to wildtype mice (Figure 3 ; Figure S3 ). We therefore sought to identify additional mechanisms engaged by BMI1 that control the pro-B cell to pre-B cell transition in developing B cells. We assessed the expression levels of the B cell transcription factors Pax5 and Ebf1, because BMI1 regulates their expression in early progenitors before lymphoid commitment (Oguro et al., 2010 ), but we found no difference in their expression between Bmi1 À/À pro-B cells and their wild-type counterparts ( Figure S4A ). To uncover other altered pathways, we sorted pro-B cells from Bmi1
and Bmi1 À/À mice and performed genome-wide expression analysis. Using a false discovery rate (FDR) < 0.05 as a cutoff for significance, we identified 122 upregulated transcripts and 165 downregulated transcripts in Bmi1 À/À pro-B cells compared to Bmi1 +/+ pro-B cells (Table S1 ). Numerous p53 targets, including Bbc3, Pmaip1, Phlda3, and Cdkn1a, were found among the upregulated transcripts in Bmi1 Table S1 ). Consistent with this observation, gene ontology analysis of upregulated genes in Bmi1 À/À pro-B cells
showed enrichment for pathways associated with apoptosis, proliferation, DNA damage, and p53 signaling ( Figure S4B ). Similarly, the p53 pathway was enriched in Bmi1 À/À pro-B cells when analyzed by gene set enrichment analysis (GSEA) ( Figure S4C ). As expected, p19 Arf expression was drastically upregulated in
Arf locus, and we confirmed the upregulation of specific p53 target genes, including Bbc3, Pmaip1, Phlda3, and Cdkn1a, in Bmi1 À/À pro-B cells from independent animals ( Figure 4B ). We did not detect changes in Trp53 transcript levels, suggesting BMI1-dependent post-transcriptional regulation of p53 activity ( Figure 4B ). Together with previous work demonstrating that deletion of p19 Arf partially restores B cell development to Bmi1 À/À mice (Akala et al., 2008; Miyazaki et al., 2008; Oguro et al., 2006) and our analysis of the expression of Bmi1 and Ckdn2a in progenitor B cells ( Figure S1A ), these findings are consistent with a role for BMI1 in preventing p53 signaling through the repression of the Ink4a/Arf locus in developing pro-B cells. p53 signaling generally results in either apoptosis or cell-cycle arrest (Kruse and Gu, 2009 ). In progenitor T cells, BMI1 prevents apoptosis through the inhibition of the p19 ARF -p53 pathway (Miyazaki et al., 2008) . Therefore, we first tested whether increased apoptosis was occurring in developing Bmi1 À/À B cells. However, we did not observe differences in the frequency of annexin V-positive pro-B cells or pre-B cells in Bmi1 À/À mice compared to wild-type counterparts ( Figure 4C ). Following successful VDJ H recombination, signaling through the pre-BCR provides survival cues and promotes the proliferation of large pre-B genotype. ***p < 0.001, **p < 0.01, *p < 0.05. PB, peripheral blood. See also Figure S4 and Table S1 . Figure 4D) . Moreover, the frequency of proliferating cells, as assessed either by DNA content or by bromodeoxyuridine (BrdU) incorporation, in the pre-B cell compartment was decreased in Bmi1 À/À animals ( Figures S4D and S4E ). We subsequently hypothesized that Bmi1
B1.8 + mice may still exhibit decreased pre-B cells numbers (Figure 3 ; Figure S3 ) due to their inability to clonally expand. Consistent with this hypothesis, there was a comparable reduction both in the proportion of large pre-B cells in the pre-B cell compartment and in the frequency of BrdU-positive pre-B cells between Bmi1 À/À mice and Bmi1 À/À B1.8 + mice ( Figures S4F and S4G) .
Finally, to demonstrate that BMI1 functions upstream of p53 to prevent B cell development, we generated a cohort of animals (p53 ), in which p53 was acutely deleted following serial injections of poly(I:C). We found that acute p53 deletion partially restored the pro-B cell to pre-B cell transition and the frequency of mature B cells in the periphery in Bmi1 À/À mice ( Figures 4E and 4F ). Alto-
gether, these data demonstrate that aberrant p53 signaling caused by BMI1 loss prevents the clonal expansion of large pre-B cells.
BMI1 Is Required for the Pro-B Cell to Pre-B Cell
Transition in a Cell-Autonomous Manner It has previously been postulated that the microenvironment of Bmi1 À/À mice is defective in supporting B cell lymphopoiesis (Oguro et al., 2010) . To test whether the defects observed in Bmi1 À/À mice reflected non-cell-autonomous effects of BMI1
on developing B cells, we generated animals in which Bmi1 is deleted selectively in pro-B cells and their progeny, using the Mb1-cre transgene (Hobeika et al., 2006) . We confirmed efficient deletion of Bmi1 and the resulting increased expression of the BMI1-target gene p19 Arf in pro-B cells sorted from Bmi1
Mb1-cre mice ( Figure 5A ). Bmi1 F/F Mb1-cre mice presented with reduced total cell numbers in their bone marrow, spleen, and peripheral blood and a roughly 2-fold reduction in the frequency of B cells in the bone marrow ( Figures S5A and S5B) . Consistent with our observations in Bmi1 À/À mice, cell-autonomous BMI1 loss impaired the pro-B cell to pre-B cell transition, as evidenced by the increased frequency of pro-B cells and the decreased frequency of pre-B cells, in the bone marrow of Bmi1 F/F Mb1-cre mice ( Figures 5B and 5C ). In addition, we observed a reduction in the frequency of B cells in the peripheral tissues of Bmi1 F/F Mb1-cre mice ( Figure 5D ). The fraction of pro-B cells expressing intracellular Igm chain was reduced in Bmi1 F/F Mb1-cre mice ( Figure 5E ), consistent with the decreased expression of rearranged Igh genes ( Figure 5F ). Again, we observed no difference in the expression of Pax5 or Ebf1 in Bmi1 F/F Mb1-cre pro-B cells ( Figure S5C ), but we did observe higher levels of p53 target genes ( Figure 5G ). Finally, subsequent deletion of p53 alleviated the pro-B cell to pre-B cell differentiation block and largely restored the frequency of mature B cells in the periphery to Bmi1 F/F Mb1-cre mice (Figures 5H and 5I ; Figure S5D ). Alto-
gether, these data demonstrate that the defects in B cell differentiation observed in Bmi1 À/À mice are largely recapitulated by cell-autonomous loss of BMI1.
DISCUSSION
Prior studies have shown that BMI1 is critical for developing lymphocytes; however, the molecular pathways BMI1 engages to promote B cell development have remained poorly defined, and whether the role of BMI1 in B cell development was cell intrinsic remained to be elucidated (Akala et al., 2008; Oguro et al., 2010; van der Lugt et al., 1994) . Our analysis identified a cell-autonomous role for BMI1 at two stages during early B cell development. Specifically, BMI1 promotes the expression of rearranged Igh genes in pro-B cells and enables large pre-B cell proliferation following pre-BCR signaling through its inhibition of p53 signaling. In adult stem cells, PRC1 directly binds to and compacts the Ink4a/Arf locus, thus repressing the expression of the cell-cycle inhibitors p16
INK4A and p19 ARF and maintaining stem cell selfrenewal capacity (Jacobs et al., 1999; Lessard and Sauvageau, 2003; Molofsky et al., 2003; Park et al., 2003) . In BMI1 null mice, the failure to develop mature lymphocytes is due to increased expression of p19 ARF , but not increased expression of p16
INK4A
, as demonstrated by genetic studies in mice (Akala et al., 2008) . In support of this observation, loss of BMI1 in developing thymocytes results in the upregulation of p19 ARF and the premature stabilization of p53, preventing DN3 T cell proliferation downstream of pre-TCR signaling (Miyazaki et al., 2008) . Past studies had demonstrated that genetic inaction of the Ink4a/Arf locus only partially restores B cell development to BMI1 null mice (Oguro et al., 2010) . These observations suggested that BMI1 functioned through unknown Ink4a/Arf-independent mechanisms to promote B cell development. It was initially postulated that this may be through non-cell-autonomous pathways, because transplantation studies suggested the bone marrow of Bmi1 À/À mice was defective at supporting B cell development (Oguro et al., 2010) . We found that in Bmi1 À/À mice, developing B cells fail to progress through the pro-B cell to pre-B cell transition due to the failure of pro-B cells to express rearranged Igh genes. Accordingly, the introduction of a pre-rearranged Igh locus largely restored B cell development to BMI1 null mice. The pre-rearranged Igh allele did not restore the ability of Bmi1 À/À large pre-B cells to clonally expand, highlighting the two distinct roles BMI1 plays during early B cell development. Finally, we recapitulated the B cell defects observed in Bmi1 À/À mice using a pro-B cell-specific Cre transgene, indicating that cell-autonomous mechanisms of BMI1 in progenitor B cells are sufficient to explain the B cell phenotypes observed in BMI1 null mice. The exact mechanism BMI1 engages to promote the expression of rearranged Igh genes remains unclear. The identification that PRC1 is recruited to sites of double-strand breaks (DSBs) and is required for their efficient repair in vitro suggests that a similar process may occur during VDJ H recombination (Facchino et al., 2010; Ginjala et al., 2011; Ismail et al., 2010) . Moreover, BMI1 associates with and recruits factors known to be critical for repair of VDJ H joints, such as ATM, KU70, and 53BP1, to sites of DSBs (Facchino et al., 2010; Pan et al., 2011; Ui et al., 2015) . However, our data demonstrate that BMI1 is not required for VDJ H recombination. In addition, we did not observe an increased frequency of gH2A.X foci at the Igh locus in Bmi1 À/À pro-B cells (data not shown). These differences may stem from the fact that BMI1 is not absolutley required but instead increases the efficiency of DSB resolution, coupled with the higher-sensitivity assays used to detect DSBs in the absence of BMI1 in vitro (Facchino et al., 2010; Ismail et al., 2010; Pan et al., 2011) . Alternatively, BMI1 may function downstream of DSB repair to enable to expression of recently damaged loci. Immediately following the generation of DSBs, BMI1 is required to prevent premature transcription of damaged genes through the deposition of H2AK119ub and the inhibition of both the FACT (facilitates chromatin transcription) histone chaperone complex and RNA polymerase II elongation (Sanchez et al., 2016; Ui et al., 2015) . In the wake of this temporal transcriptional silencing, new uniquely marked histones, such as H3.3, are deposited. The deposition of H3.3 primes recently damaged chromatin and is required for transcription restart (Adam et al., 2013) . Another study demonstrated that FACT-mediated histone exchange was required for transcription restart following UV damage (Dinant et al., 2013) . However, no studies have demonstrated what happens to transcription restart at sites of DSBs if the initial transcriptional repression does not occur. It is therefore possible that BMI1-dependent transcriptional silencing following the generation of DSBs is required to permit the proper turnover of histones and subsequent re-expression of repaired genes, in this case the recently rearranged Igh genes. BMI1 is overexpressed in several hematologic malignancies, and its upregulation predicts poor prognosis in pediatric B cell acute lymphoblastic leukemia (B-ALL), the most common cancer in children (Peng et al., 2017; Sahasrabuddhe, 2016) . Work has shown that pre-BCR and downstream signaling promote the aggressiveness of certain subtypes of B-ALL and can be targeted to eliminate human and mouse B-ALL cells (Eswaran et al., 2015; Feldhahn et al., 2005; Geng et al., 2015; Rickert, 2013) . It is therefore tempting to speculate that increased BMI1 expression promotes the inappropriate proliferation of B-ALL cells downstream of pre-BCR signaling in a process analogous to what we observed in normal developing B cells. If so, BMI1-dependent signaling might present a novel therapeutic approach to target B-ALL cell growth. Along these lines, a chemical inhibitor specific to BMI1 was identified and well tolerated in mice (Kreso et al., 2014) . Moreover, the inhibitor has been shown to be effective in various cancer cells (Kreso et al., 2014; Yong et al., 2016) .
Our study clarifies the function of BMI1 in early B cell development, revealing a critical role for BMI1 for the expression of rearranged Igh genes in pro-B cells and the clonal expansion of large pre-B cells, and adds to the expanding range of BMI1's function in vivo.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
ACKNOWLEDGMENTS
We are grateful to all members of the David laboratory for helpful discussions during the preparation of the manuscript. We wish to acknowledge the Skirball Institute of Biomolecular Medicine for hosting our laboratory following Hurricane Sandy. We thank the NYU Cytometry and Cell Sorting Core (supported in part by NIH/NCI support grant P30CA016087) for help with analysis and cell sorting. We thank the NYU Genome Technology Center 
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Gregory David (Gregory.David@nyulangone.org).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mx1-Cre, Bmi1
F/+ , Mb1-cre, and p53 F/+ mice were purchased from The Jackson Laboratory and have been described (Hobeika et al., 2006; K€ uhn et al., 1995; Marino et al., 2000; Maynard et al., 2014) . Bmi1 +/À mice were a kind gift from Maarten van Lohuizen and have been described (van der Lugt et al., 1994) . B1.8i mice were a kind gift from Klaus Rajewsky and have been described (Sonoda et al., 1997) . Animals were housed in specific pathogen-free conditions at the Skirball Animal Facility. Aged matched controls were used for Bmi1 germline mutant mice whereas littermate controls were used for Bmi1 F/F Mb1-cre mice. Female and male mice were used depending on availability. All mice were analyzed at 4-8 weeks of age. All animal experiments were done in accordance with the guidelines of the NYU School of Medicine Institutional Animal Care and Use Facility.
METHOD DETAILS
Mouse treatment
For induction of Cre-mediated deletion of loxP-flanked p53 alleles in the Bmi1 p53 Mx1-Cre animal cohort, poly(I:C) (InvivoGen) was administered by i.p. injection at 5mg kg -1 in PBS for 3 injections on alternating days at 3 weeks of age. Animals were analyzed two weeks following the last poly(I:C) injection.
Flow cytometry analysis and cell sorting Single cell suspensions were derived from bone marrow (femur and tibia of both hind legs), spleen, thymus, and peripheral blood. Red blood cells were lysed with ACK lysis buffer. Cell counts were determined using a cell counter (Beckman Coulter) set to detect nuclei between 3.5uM and 10uM or manually with a hemocytometer. All cells were blocked with purified rat IgG (20ug ml -1 ) for 15 min on ice prior to antibody staining. The following antibodies were used for analysis (from Biolegend): anti-B220 (RA3-6B2), anti-CD19 (6D5), anti-CD4 (RM4-5), anti-CD8 (53-6.7), anti-CD11b (M1-70), anti-Gr1 (RB6-8C5), anti-TER119 (TER119), anti-CD25 (PC61), anti-IgM (RMM-1), anti-IgD (11-26c.2a), and anti-ckit (2B8). Cells were stained with primary antibodies for 30 min on ice. For intracellular staining of Igm chain, cells were first stained for surface markers followed by fixation and permeabilization with BD Cytofix/Cytoperm for 30 min at room temperature. Cells were then incubated with an Igm specific Fab fragment (Jackson ImmunoResearch) for 45 min on ice. PI (1ug ml -1 ), DAPI (500ng ml -1 ), 7aad (1ug ml -1 ), or Zombie fixable dye was added following staining for the exclusion of dead cells. Cells were identified based on the cell-surface phenotypes described in Table S2 . Cells were analyzed on a LSRII (BD Biosciences) or sorted on an AriaI or AriaII (BD Biosciences). Data were analyzed with FlowJo software (FlowJo, LLC).
RNA-sequencing RNA was isolated from FACS purified pro-B cells. RNA was harvested from 2 biological replicates using the RNeasy Micro Kit (QIAGEN). RNA quantification and quality was determined using an Aglient 1200 Bioanalyzer. Strand-specific libraries were prepared using the SMARTer low-input RNA kit. Libraries were sequenced on an Illumina HiSeq2500 using 50bp paired-end reads. Fastq files were aligned to mm9 using TopHat. Differential expression tests were done using the Cuffdiff module of Cufflinks against the Refseq annotation. We used an FDR < 0.05 as a cutoff for significance. Gene set enrichment analysis was performed using log 2 fold change as metric for ranking genes and 1,000 permutations. Gene sets used in this study were identified from the Molecular Signatures Database (Curated v5.0 and Hallmarks v5.0).
Cell cycle analysis
For cell cycle analysis of pre-B cells, cells were stained for surface markers, fixed and permeabilized with BD Cytofix/Cytoperm for 30 min at room temperature, and incubated with DAPI (10mg ml -1 ) and RNaseA (50mg ml -1 ) for 30 min at room temperature. For BrdU incorporation analysis of pre-B cells, mice were i.p. injected with 1mg BrdU and sacrificed 2 hr later. Cells were stained for surface markers and analyzed for BrdU incorporation as described using the BD PharMingen BrdU Flow Kit. Apoptotic cells were detected using the Annexin V Apoptosis Detection Kit (Biolegend) according to the manufacturer's instructions.
RT-qPCR analysis RNA from sorted cell populations was isolated using the RNeasy Mini Kit (QIAGEN). Prior to reverse transcription, RNA was incubated with DNase I (Promega). RNA was subsequently converted into cDNA using either M-MLV reverse transcriptase (Promega) or Maxima reverse transcriptase (Thermo Scientific) according to the manufacturer's instructions, using an equal mix of oligo dT and random hexamers as primers. Real-time quantitative PCR (RT-qPCR) was performed on a Bio-rad iCycler using Maxima SYBR Green master mix (Thermo Scientific) according to the manufacturer's instructions. No-RT controls were included to ensure no genomic DNA contamination was present. All values were normalized to Hprt levels using the DCt method. RT-PCR primer pairs are shown in Table S3 .
Semiquantitative PCR analysis of VDJ H joints
Genomic DNA from sorted cell populations was isolated using the DNeasy Blood and Tissue kit (QIAGEN). Igh rearrangements were amplified as previously described (Fuxa et al., 2004) . Briefly, serial dilutions of genomic DNA were amplified using a forward primer specific to either the D H , the V H 7183 family, or the V H J558 family and a reverse primer specific to J H3 . Primers specific to Cm were used as a loading control. PCRs were run in the linear range and products were run on a 1.25% agarose gel. Primer pairs are shown in Table S4 .
Sub-clonal sequencing of VDJ H joints Genomic DNA from sorted pro-B cells was isolated using the DNeasy Blood and Tissue kit (QIAGEN). Igh rearrangements were amplified using a promiscuous forward primer (MsVHe) (5 0 -GGGAATTCGAGGTGCAGCTGCAGGAGTCTGG-3 0 ) that binds to genes within all V H families and a reverse primer specific to J H3 (5 0 -GTCTAGATTCTCACAAGAGTCCGATAG ACCCTGG-3 0 ). A high fidelity polymerase (Roche) was used to minimize point mutations during PCR amplification. The amplified product was run on a 1% agarose gel and the expected band size ($450bp) was excised and purified. The purified DNA product was inserted into the pGEM-T easy vector (Promega) according to the manufacturers instructions. Subcloned DNA was column purified (QIAGEN) and sequenced using T7 primer (Macrogen). VDJ H sequences were analyzed using the National Center for Biotechnology Information's IgBlast program.
DNA FISH
DNA FISH was performed with the probes BACs CT7-199M11 (3' Igh) and CT7-526A21 (5' Igh) labeled by nick translation. For each 22x22 mm coverslip, 1 mg of labeled BAC DNA, 10 mg of sheared salmon sperm DNA and 1 mg of Cot-1 (Life Technologies) were precipitated and resuspended in 16 mL of hybridization buffer (50% formamide/20% dextran sulfate/5X denhardt's solution). DNA FISH was carried out as previously described (Chaumeil et al., 2008) . Briefly, cells were adhered to poly-L-lysine coated coverslips for 10 min, fixed for 10 min at 22 C with 2% (wt/vol) paraformaldehyde/PBS and permeabilized for 10 min with 0.5% (vol/vol) Triton/ PBS. Coverslips were incubated with RNaseA (0.1 mg/ml in PBS, 30 min at 37 C), then re-permeabilized for 10 min at 0 C in 0.7% (vol/vol) Triton X-100 / 0.1 M HCl. Cells were then placed in 50% formamide/2XSSC for 1 hr at 22 C. Coverslips and resuspended probes were then placed at 75 C for 2 min, before probes were applied to coverslips, sealed onto slides with rubber cement, followed by incubation overnight at 37 C. Cells were then washed two times with 50%formamide/2xSSC at 42 C, two times with 2xSSC at 42 C and 1xSSC at 42 C, for 5 min each and were mounted in Prolong Gold (Life Technologies) containing 1.5 mg/ml DAPI.
Confocal microscopy and analysis DNA FISH was imaged by confocal microscopy on a Leica SP5 AOBS system (Acousto-Optical Beam Splitter). Optical sections separated by 0.3 mm were collected and only cells with signals from both alleles were analyzed using ImageJ software (NIH). For distance measurements in DNA FISH, ImageJ was used to measure the center of mass of each focus and calculate intralocus distances.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis was performed using an unpaired Student's two-tailed t test. Differences in the distribution of intralocus distance between the 5' and 3' Igh FISH probes was compared using the Kolmogorov-Smirnov test. All experiments were performed in the number of biological replicates mentioned as n in the figure legends or shown as individual points in figures. N represents individual sequences for pro-B cell subclonal VDJ H joint sequencing, individual cells for DNA FISH assessing Igh contraction, and individual animals for all other experiments. A p value < 0.05 was considered statistically significant. All data were analyzed using GraphPad Prism software.
DATA AND SOFTWARE AVAILABILITY
RNA-sequencing data were deposited at GEO and is available under accession GEO: GSE119422. 
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